Abstract:Motivation Among many large-scale proteomic quantification methods, 18O/16O labeling requires neither specific amino acid in peptides nor label incorporation through several cell cycles, as in metabolic labeling; it does not cause significant elution time shifts between heavy- and light-labeled peptides, and its dynamic range of quantification is larger than that of tandem mass spectrometry-based quantification methods. These properties offer 18O/16O labeling the maximum flexibility in application. However, 18O/16O labeling introduces large quantification variations due to varying labeling efficiency. There lacks a processing pipeline that warrants the reliable identification of differentially expressed proteins (DEPs). This motivates us to develop a quantitative proteomic approach based on 18O/16O labeling and apply it on Kaposi sarcoma-associated herpesvirus (KSHV) microRNA (miR) target prediction. KSHV is a human pathogenic y-herpesvirus strongly associated with the development of B-cell proliferative disorders, including primary effusion lymphoma. Recent studies suggest that miRs have evolved a highly complex network of interactions with the cellular and viral transcriptomes, and relatively few KSHV miR targets have been characterized at the functional level. While the new miR target prediction method, photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation (PAR-CLIP), allows the identification of thousands of miR targets, the link between miRs and their targets still cannot be determined. We propose to apply the developed proteomic approach to establish such links. Method We integrate several 18O/16O data processing algorithms that we published recently and identify the messenger RNAs of downregulated proteins as potential targets in KSHV miR-transfected human embryonic kidney 293T cells. Various statistical tests are employed for picking DEPs, and we select the best test by examining the enrichment of PAR-CLIP-reported targets with seed match to the miRs of interest among top ranked DEPs returned by statistical tests. Subsequently, the list of DEPs picked by the selected statistical test is filtered with the criteria that they must have downregulated gene expressions, must have reported as targets by an miR target prediction algorithm SVMcrio, and must have reported as targets by PAR-CLIP. Result We test the developed approach in the problem of finding targets of KSHV miR-K1. The RNAs of three DEPs are identified as miR-K1 targets, among which RAB23 and HNRNPU are novel. Results from both Western blotting and Luciferase reporter assays confirm the novel targets. These results show that the developed quantitative approach based on 18O/16O labeling can be combined with genomic, PAR-CLIP, and target prediction algorithms for the confident identification of KSHV miR targets. The developed approach could also be applied in other applications.

Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip)

Translational control analysis by translationally active RNA capture/microarray analysis (TrIP-Chip).

Quantification of Microrna by DNA-Peptide Probe and Liquid Chromatography-Tandem Mass Spectrometry-Based Quasi-Targeted Proteomics.

Identifying Cancer-Related Micrornas Based on Gene Expression Data

Capturing microRNA targets using an RNA-induced silencing complex (RISC)-trap approach

Predicting MicroRNA Targets by Integrating Sequence and Expression Data in Cancer

Amplification-free microRNA profiling with femtomolar sensitivity on a plasmonic enhanced fluorescence nano-chip

Integrative Approaches for Microrna Target Prediction: Combining Sequence Information and the Paired Mrna and Mirna Expression Profiles

Systematic Identification And Assessment Of Therapeutic Targets For Breast Cancer Based On Genome-Wide Rna Interference Transcriptomes

Transcriptome and Targetome Analysis in MIR155 Expressing Cells Using RNA-seq.

A Bayesian Approach for Identifying Mirna Targets by Combining Sequence Prediction and Expression Profiling

High-resolution in vivo identification of miRNA targets by Halo-Enhanced Ago2 Pulldown

An Integrated Analysis Method for Mirna, Lncrna and Mrna Profiles Based on Their Functional and Positional Relationships

A strategy to rapidly identify the functional targets of microRNAs by combining bioinformatics and mRNA cytoplasmic/nucleic ratios in culture cells.

Target-induced multipath-to-one-substrate approach for high-efficient bioanalysis of microRNA

An in Vivo Method to Identify Microrna Targets Not Predicted by Computation Algorithms: P21 Targeting by Mir-92A in Cancer.

High-throughput and ultra-sensitive single-cell profiling of multiple microRNAs and identification of human cancer.

Quantitative Profiling of in Vivo-Assembled Rna-Protein Complexes Using A Novel Integrated Proteomic Approach

Quantitative Proteomic Approach for MicroRNA Target Prediction Based on 18O/16O Labeling

Computational Identification of RNA-Seq Based miRNA-Mediated Prognostic Modules in Cancer

MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.